Article Details
Retrieved on: 2021-03-10 13:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Infinity is a clinical-stage biotechnology company developing eganelisib, a potentially first-in-class, oral, immuno-oncology macrophage ...
Article found on: www.pharmiweb.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here